Regulatory News has published 1 story about Quoin Pharmaceuticals on 29 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 29 September 2026.
This page is generated from Regulatory News’ editorial coverage of Quoin Pharmaceuticals. It is not an advertisement.
On the record
- Company
- Quoin Pharmaceuticals, Ltd. (Nasdaq: QNRX)
- Headquarters
- Ashburn, Virginia
- Founded
- 2018, as Quoin Inc.; began trading on Nasdaq in October 2021 following a combination with Cellect Biotechnology Ltd.
- Regulator
- U.S. Food and Drug Administration
- Latest milestone
- FDA Fast Track Designation, QRX003 for Peeling Skin Syndrome
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
